dsRNA for treating viral infection

Details for Australian Patent Application No. 2008270209 (hide)

Owner Novartis AG

Inventors Labow, Mark Aron; Borawski, Jason; Gaither, Larry Alexander

Agent Davies Collison Cave

Pub. Number AU-B-2008270209

PCT Pub. Number WO2009/004085

Priority 60/948,100 05.07.07 US

Filing date 4 July 2008

Wipo publication date 8 January 2009

Acceptance publication date 17 May 2012

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2009/004085 Priority application(s): WO2009/004085

17 May 2012 Application Accepted

  Published as AU-B-2008270209

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008270218-Compounds and methods for the treatment of renal disease

2008270207-Method, apparatus and system for mobility management and efficient information retrieval in a communications network